menu

CME: Uncontrolled Moderate-to-Severe-Asthma: Latest Data from the Floor of CHEST 2018

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Uncontrolled Moderate-to-Severe-Asthma: Latest Data from the Floor of CHEST 2018

Uncontrolled Moderate-to-Severe-Asthma: Latest Data from the Floor of CHEST 2018
RestartResume
For those patients with severe asthma who may experience serious exacerbations, new data from clinical trials could transform the quality of care.

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Not only do serious exacerbations interfere with a patient’s daily activities, but they also account for much of the morbidity and mortality associated with asthma, as well as at least half of asthma-related costs. That’s why clinicians need information about new research to optimize their management of patients with severe asthma.

    Live from the CHEST Annual Meeting in San Antonio, TX, Dr. Jennifer Caudle is joined by pulmonary experts Dr. Eugene Bleeker, Dr. Mario Castro, and Dr. Nicola Hanania to discuss the emerging science of severe asthma, new approaches to its treatment, and what the future might hold for clinicians and their patients.

  • Jointly Provided By:

     

  • Commercial Support

    Supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

  • Method of Participation

    Participants should read the activity information, review the activity in its entirety, and complete the online post-test and evaluation. Upon completing this activity as designed and achieving a passing score on the post-test, you will be directed to a Web page that will allow you to receive your certificate of credit via e-mail or you may print it out at that time. The online post-test and evaluation can be accessed at the end of the audio program. Inquiries may be directed to Global Academy for Medical Education at info@globalacademycme.com or (973) 290-8225 or Postgraduate Institute for Medicine at (720) 895-5357.

  • Target Audience

    This activity is intended for pulmonologists, family practitioners, internists, physician assistants, nurse practitioners, and other clinicians who treat patients with asthma.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Apply new findings from clinical trials to the management of patients with severe asthma
  • Accreditation and Credit Designation Statements

    Statement of Need
    Patients with severe asthma may experience repeated serious exacerbations that interfere with daily activities. They account for much of the morbidity and mortality associated with asthma, as well as at least half of asthma-related costs. New analyses of data from clinical trials may suggest improved strategies for asthma patient care. Clinicians need information about new research to optimize their management of patients with severe asthma.

    CME Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Chest Physicians (CHEST) and Global Academy for Medical Education. The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians.

    The American College of Chest Physicians designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Joint Accreditation Statement


    In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Continuing Nursing Education
    The maximum number of hours awarded for this Continuing Nursing Education activity is 0.7 contact hours. Designated for 0.7 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

    Maintenance of Certification (MOC) Statement
    Successful completion of this CME activity enables the participant to earn up to .5 MOC points in The American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

    Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion Information to ACCME for the purpose of granting ABIM MOC points. Upon successful completion of this course, CHEST will submit your completion data to ABIM via ACCME's Program and Activity Reporting System (PARS) for MOC points. Please allow 30 days after claiming for points to appear on your ABIM record.

  • Disclosure Declarations

    Individuals in a position to control the content of this educational activity are required to disclose: 1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with ACCME-defined commercial interests related to the content of this CME activity:

    Eugene R. Bleecker, MD, Grant/Research Support: AstraZeneca, Boehringer Ingelheim, Genentech, Johnson and Johnson (Janssen), MedImmune, Novartis, Regeneron, and Sanofi Genzyme. Consultant: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, MedImmune, Novartis, Regeneron, and Sanofi Genzyme.

    Mario Castro, MD, Consultant: 4D Pharma, Aviragen, Boston Scientific, Genentech, Mallincrodt, Neutronic, Nurvaira,  Therabron, Theravance, Teva, VIDA, and Sanofi-Aventis. Grant/Research Support: AstraZeneca Boehringer Ingelheim, Chiesi, Novartis, and Sanofi Aventis. Speakers’ Bureau: Astra-Zeneca, Boehringer Ingelheim, Boston Scientific, Genentech, and Teva. Royalty: Elsevier.

    Nicola Hanania, MD, Consultant: AstraZeneca, GlaxoSmithKline, Novartis, and Sanofi Genzyme.
    Grant/Research Support: AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline.

    American College of Chest Physicians (CHEST) Staff has nothing to disclose.
    The Postgraduate Institute for Medicine planners and managers have nothing to disclose.
    Global Academy for Medical Education planners and managers have nothing to disclose.

    Disclosure of Unlabeled Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Disclaimer

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

    Copyright © 2018 by Global Academy for Medical Education, LLC, Frontline Medical Communications Inc.,  and  its  Licensors.  All  rights  reserved.  No  part  of  this  publication  may  be  reproduced  or transmitted in any form, by any means, without prior written permission of the Publisher. Global Academy for Medical Education, LLC, Global Education Group, and Frontline Medical Communications will  not  assume  responsibility  for  damages,  loss,  or  claims  of  any  kind  arising  from  or  related  to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.